- Abstract:
-
Background
Increasing access to essential respiratory medicines and influenza vaccination has been a priority for over three decades. Their use remains low in low- and middle-income countries (LMICs), where little is known about factors influencing use, or about the use of influenza vaccination for preventing respiratory exacerbations.
Methods
We estimated rates of regular use of bronchodilators, inhaled corticosteroids and influenza vaccine, and predictors for use...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted manuscript
- Files:
-
-
(pdf, 609.3KB)
-
- Publisher copy:
- 10.5588/ijtld.14.0263
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- IngentaConnect Publisher's website
- Journal:
- International Journal of Tuberculosis and Lung Disease Journal website
- Volume:
- 19
- Issue:
- 1
- Pages:
- 21-30
- Publication date:
- 2015-01-05
- DOI:
- EISSN:
-
1815-7920
- ISSN:
-
1027-3719
- URN:
-
uuid:c15b28ed-a74f-44d2-8d1e-984b2ec457cf
- Source identifiers:
-
566472
- Local pid:
- pubs:566472
- Copyright holder:
- International Union Against Tuberculosis and Lung Disease
- Copyright date:
- 2015
- Notes:
- © 2015 The Union
Journal article
Gaps In using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
ALTANA
More from this funder
Aventis
More from this funder
AstraZeneca
More from this funder
Boehringer-Ingelheim
More from this funder
Chiesi
More from this funder
Expand funders...
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record